Article
Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes.
Haematologica - 1 Jan 2000
Camaschella C, Gonella S, Calabrese R, Vischia F, Roetto A, Graziadei G, Mazza U, Cappellini M D
Abstract excerpt
BACKGROUND: Thalassemia intermedia patients usually do not require blood transfusions; however, all show variable degrees of erythropoietic marrow expansion to compensate for more or less marked anemia, and this represents the major cause of complications in untransfused individuals. MATERIALS AND METHODS: To assess the degree of erythropoietic expansion in thalassemia intermedia, serum erythropoietin (sEpo) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.